InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.036

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 App 3Z Final Directors Interest Notice - M Glass 18 Feb 2019 8:20AM $0.017 $0.036 risen by 111.76%
$4 Appendix 3B - issue of shares and unlisted share options 12 Feb 2019 3:19PM $0.018 $0.036 risen by 100%
$4 Invion completes spin-out of respiratory assets 12 Feb 2019 8:24AM $0.017 $0.036 risen by 111.76%
$4 General Meeting - Results of Meeting 30 Jan 2019 1:07PM $0.018 $0.036 risen by 100%
$4 CEO Update to General Meeting 30 Jan 2019 11:24AM $0.017 $0.036 risen by 111.76%
$4 Invion selects Guilin Xingda for light-therapy manufacture 29 Jan 2019 8:32AM $0.018 $0.036 risen by 100%
$4 Appendix 4C - December quarter 29 Jan 2019 8:31AM $0.018 $0.036 risen by 100%
$4 Invion appoints cancer experts to Scientific Advisory Board 16 Jan 2019 8:25AM $0.018 $0.036 risen by 100%
$4 Appendix 3Y - Change in Director Interests - Thian Chew 24 Dec 2018 8:20AM $0.018 $0.036 risen by 100%
$4 General Meeting - Notice of Meeting 21 Dec 2018 12:01PM $0.019 $0.036 risen by 89.47%
$4 Respiratory Assets Demerger - Receipt of draft Class Ruling 21 Dec 2018 11:59AM $0.019 $0.036 risen by 89.47%
$4 Appendix 3Y - Change in Director Interests - Thian Chew 14 Dec 2018 3:48PM $0.018 $0.036 risen by 100%
$4 Demerger of respiratory assets - update 29 Nov 2018 1:07PM $0.019 $0.036 risen by 89.47%
$4 Ceasing to have an interest over shares 19 Nov 2018 8:27AM $0.024 $0.036 risen by 50%
$4 Appendix 3B - lapse of unlisted share options 19 Nov 2018 8:26AM $0.024 $0.036 risen by 50%
$4 Notification regarding release of escrowed securities 19 Nov 2018 8:26AM $0.024 $0.036 risen by 50%
$4 Invion Constitution adopted 13 November 2018 16 Nov 2018 1:42PM $0.024 $0.036 risen by 50%
$4 Annual General Meeting - Results of Meeting 13 Nov 2018 1:09PM $0.024 $0.036 risen by 50%
$4 Chairman's Address and CEO Presentation to AGM 13 Nov 2018 11:17AM $0.024 $0.036 risen by 50%
$4 Invion collaborates to develop powerful skin cancer gel 7 Nov 2018 8:23AM $0.023 $0.036 risen by 56.52%
$4 Appendix 4C - September 2018 quarter 29 Oct 2018 9:39AM $0.027 $0.036 risen by 33.33%
$4 CAT appoints R&G Pharma as CRO for nadolol in China 27 Sep 2018 8:29AM $0.036 $0.036 fallen by 0%
$4 New Photosoft formulation increased effect in ovarian cancer 25 Sep 2018 8:31AM $0.035 $0.036 risen by 2.86%
$4 AGM Notice of Meeting 24 Sep 2018 4:59PM $0.035 $0.036 risen by 2.86%
$4 Photosoft granted Australian patent and Business Update 10 Sep 2018 8:36AM $0.035 $0.036 risen by 2.86%

451 - 475 of 717 results

Page 19 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.